Publication | Closed Access

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study

HepatologyViral HepatitisPharmacologyHepatitis BHepatitisAntiviral TherapyChronic Hepatitis BPharmacotherapyMedicineTenofovir Disoproxil FumaratePhase 3